Tuesday, May 10, 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

No comments:

Post a Comment

Amber Discovered For the First Time in Antarctica: What You Need to Know

The discovery of amber in Antarctica has been reported for the first time, as detailed in a recent study published in Antarctic Science. Dr...